<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rituximab has improved the treatment of B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>While it is generally well tolerated, serious adverse effects including infusion reactions with hemodynamic compromise and <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> or <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> are possible </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary vasospasm</z:e> occurring during a rituximab infusion in a patient with minimal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> burden and who had no cardiac risk factors </plain></SENT>
<SENT sid="3" pm="."><plain>This case highlights that determination of the cause of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is important and may identify some patients who can be successfully rechallenged </plain></SENT>
</text></document>